Bioinformatic analyses of the GSE45553 and GSE73935 datasets indicated that NTNG1 was a candidate gene involved in cisplatin resistance in ovarian cancer; the BioGRID demonstrated an interaction between NTNG1 and GAS6. This evidence concerns the gene NTNG1 and ovarian carcinoma.